Tim Noyes

Tim has 30 years of industry experience leading all aspects of R&D and commercialization in the biopharmaceutical industry including Merck, Genzyme, and Proteon. He has extensive launch planning and commercial launch experience and at Genzyme, he headed all launch planning and the commercialization of Renagel, a treatment for hemodialysis patients that resulted in Genzyme’s acquisition of GelTex for more than $1 billion.

Location

Waltham, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Aerovate Therapeutics

Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease.


Industries

Employees

11-50

Links